Active substanceMethyl ethylpyridinolMethyl ethylpyridinol Similar drugsTo uncover Cardiocipine solution d / infusion BIOSINTEZ, PAO Russia Cardiocipine solution w / m in / in BIOSINTEZ, PAO Russia Methyl ethylpyridinol solution for injections ATOLL, LLC Russia Methyl ethylpyridinol solution for injections ELLARA, LTD. Russia Methyl ethylpyridinol solution for injections Company DEKO, LLC Russia Methyl ethylpyridinol-Eskom solution for injections ESKOM NPK, OAO Russia Emoticon Optics drops d / eye SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products Russia Emoxibel solution d / infusion Emoxibel solution for injections BELMEDPREPARATY, RUP Republic of Belarus Emoxibel drops d / eye BELMEDPREPARATY, RUP Republic of Belarus Emoxibel solution w / m in / in BELMEDPREPARATY, RUP Republic of Belarus Emoxipine® drops d / eye MOSCOW ENDOCRINE FACTORY, FSUE Russia Emoxipine solution w / m in / in MOSCOW ENDOCRINE FACTORY, FSUE Russia Emoxipine drops d / eye FARMENT FIRM, LLC Russia Emoxipine solution for injections MOSCOW ENDOCRINE FACTORY, FSUE Russia Emoxipine-AKOS drops d / eye SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products Russia Emoxipine-Acti solution d / infusion Aktifarm, OOO Russia Dosage form: & nbspA solution of 1% drops eye. Composition:Active substances:Emoxipine - 10.0 g Excipients:Sodium sulfite anhydrous - 3.0 gSodium benzoate 2.0 gPotassium phosphate monosubstituted - 6.2 gSodium phosphate disubstituted - 7.5 gMethyl cellulose 5.0 gWater for injection - up to 1 liter Description:Colorless or slightly colored slightly opalescent liquid. Pharmacotherapeutic group:Antioxidant. ATX: & nbspS.01.X.A Other drugs for the treatment of eye diseases Pharmacodynamics:Emoksipin reduces capillary permeability, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces clotting and blood viscosity, has anti-aggregation and antihypoxic effects. Indications:- treatment and prevention of inflammation and burns of the cornea;- treatment of hemorrhages in the anterior chamber of the eye;- treatment of complications with myopia;- protection of the cornea when wearing contact lenses;- prevention and treatment of scleral hemorrhage in the elderly. Contraindications:Individual hypersensitivity to the components of the drug, pregnancy. Dosing and Administration:The drug is instilled in the conjunctival cavity 1-2 drops 2-3 times a day. The course of treatment is 3-30 days. If necessary and good tolerability of the drug, the course of treatment can be continued up to 6 months or repeated 2-3 times a year. Side effects:Perhaps a burning sensation, itching, short-term conjunctival hyperemia, rarely the development of local allergic reactions. Interaction:Emoksipina solution should not be mixed with other medicinal solutions.If it is necessary to use other eye drops at the same time, Emoksipin should be instilled last, after full absorption of the previous drops (not less than 10-15 minutes). Form release / dosage:A solution of 1% drops eye. Packaging:5ml and 10ml in bottles, bottles of dark glass.By 5ml and 10ml in bottles-dropper polymer. Storage conditions:List B. In the dark place at a temperature not higher than 25 ° C and not accessible place for children. Shelf life:2 years. Do not use after the expiry date printed on the package! Terms of leave from pharmacies:On prescription Registration number:P N002264 / 01-2003 Date of registration:23.07.2009 Expiration Date:Unlimited The owner of the registration certificate:SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products Russia Manufacturer: & nbspSYNTHESIS, OJSC Russia Information update date: & nbsp2016-08-27 Illustrated instructions × Illustrated instructions Instructions